All aforementioned factors, including underlying conditions such as cancers, active bacterial/viral infections, connective tissue diseases, ongoing hormonal or chemotherapies which would have affected baseline CRP levels, were unaccounted for and would have contributed to heterogeneity amongst our study group, and could have introduced/contributed towards bias in our produced results. The gene discussed is CRP; the disease is viral infectious disease.